Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: J Med Virol. 2024 Jan;96(1):e29333. doi: 10.1002/jmv.29333

Table 3.

Among 634 who responded to questions about rebound and Long COVID, although 26% experienced rebound symptoms, rebound test positivity, or both, there was not a statistically significant difference in the presence of Long COVID among those who experienced rebound compared to those who did not (OR 1.34; 95%CI 0.74–2.41; p=.33).

No Rebound Rebound Symptoms or Test Positivity Total
No Long COVID symptoms 429 (91.7%) 148 (90.2%) 577 (91.0%)
≥1 Long COVID symptom 39 (8.3%) 18 (10.8%) 57 (9.0%)
Total 468 (73.8%) 166 (26.2%) 634 (100%)